Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study

被引:127
作者
McNeill, Ann Marie
Katz, Ronit
Girman, Cynthia J.
Rosamond, Wayne D.
Wagenknecht, Lynne E.
Barzilay, Joshua I.
Tracy, Russell P.
Savage, Peter J.
Jackson, Sharon A.
机构
[1] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA
[2] Univ Washington, Collaborat Hlth Studies Coordinating Ctr, Seattle, WA 98195 USA
[3] Merck Sharp & Dohme Ltd, Res Labs, Dept Epidemiol, West Point, PA 19486 USA
[4] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA
[5] Kaiser Permanente, Div Endocrinol, Atlanta, GA USA
[6] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[7] Univ Vermont, Coll Med, Lab Clin Biochem Res, Burlington, VT USA
[8] NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA
关键词
aging; cardiovascular diseases; epidemiology; metabolic syndrome;
D O I
10.1111/j.1532-5415.2006.00862.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To assess the prospective association between metabolic syndrome (MetS) and cardiovascular disease (CVD) in older people and to evaluate the effect of lowering the threshold for impaired fasting glucose (IFG) on the prevalence of IFG and MetS and the risk of CVD. DESIGN: Prospective cohort study. SETTING: Four field centers in U.S. communities. PARTICIPANTS: Three thousand five hundred eighty-five subjects in the Cardiovascular Health Study free of diabetes mellitus and CVD at baseline (mean age 72, 62% female, 14% black). MEASUREMENTS: Baseline measures of MetS components and adjudicated incident CVD events. MetS (2001) was defined first using the original criteria from the Third Adult Treatment Panel Report of the National Cholesterol Education Program (>= 3 of the following: large waist circumference (women > 88 cm, men > 102 cm), elevated triglycerides (>= 1.70 mmol/L), low high-density lipoprotein cholesterol (men < 1.04 mmol/L, women < 1.30 mmol/L), elevated fasting glucose (6.1-6.9 mmol/L), and high blood pressure (>= 130/85 mmHg or self-reported use of medications for hypertension). Subjects were also classified according to the revised definition of the MetS (2005) that applies the lower threshold for fasting glucose (5.6-6.9 mmol/L). RESULTS: During follow-up (median 11 years), 818 coronary heart disease (CHD), 401 stroke, and 554 congestive heart failure (CHF) events occurred. Age- and race-adjusted hazard ratios (HRs) for CHD, stroke, and CHF were 1.30 (95% confidence interval (CI)=1.07-1.57), 0.94 (95% CI=0.73-1.21), and 1.40 (95% CI=1.12-1.76) for women and 1.35 (95% CI=1.10-1.66), 1.51 (95% CI=1.08-2.12), and 1.47 (95% CI=1.14-1.90) for men, respectively. Overall, women and men with MetS (2005) were 20% to 30% more likely to experience any CVD event than subjects without MetS (2005). Using the lower cut-point for IFG resulted in a near tripling in IFG prevalence (16% to 46%) and an additional 9% classified with MetS (2005) but HRs similar to those estimated from the original MetS (2001) criteria. High blood pressure was the component most strongly associated with incident CHD. CONCLUSIONS: Results from this study of an elderly, population-based cohort provide support for earlier investigations in primarily middle-aged populations that link the presence of MetS with the development of CVD and further underscore the importance of recognizing and treating its individual components, particularly high blood pressure.
引用
收藏
页码:1317 / 1324
页数:8
相关论文
共 27 条
[1]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[2]   Carotid atherosclerosis and coronary heart disease in the metabolic syndrome - Prospective data from the Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2003, 26 (04) :1251-1257
[3]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[4]  
CUSHMAN M, 1995, CLIN CHEM, V41, P264
[5]   Lowering the criterion for impaired fasting glucose will not provide clinical benefit [J].
Davidson, MB ;
Landsman, PB ;
Alexander, CM .
DIABETES CARE, 2003, 26 (12) :3329-3330
[6]   Obesity in 70-year-old subjects as a risk factor for 15-year coronary heart disease incidence [J].
Dey, DK ;
Lissner, L .
OBESITY RESEARCH, 2003, 11 (07) :817-827
[7]  
Fried Linda P., 1991, Annals of Epidemiology, V1, P263
[8]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[9]  
Geiss LS, 1995, MORTALITY NONINSULIN
[10]  
Genuth S, 2003, DIABETES CARE, V26, P3160